Quarterly Activities/Appendix 4C Cash Flow Report
Released
Released
Announcement PDF
ASX ANNOUNCEMENT
30th January 2026
HITIQ LTD Unit 4/38-42 White Street, South Melbourne 3205
ASX:HIQ investors@hitiq.com
ACN 609 543 213 www.hitiq.com
HITIQ Quarterly Activities Report
December 2025
Highlights
• North American Market Expansion: Launched PROTEQT© North American
market strategy through an exclusive Canadian distribution partnership,
providing immediate access to one of the world’s largest collision-sport markets
and a pathway into the United States.
• Retail Distribution Commenced: Entered national retail distribution with Rebel,
Australia’s leading sporting goods retailer, marking a major milestone in
consumer market rollout and brand visibility, PROTEQT© will be on sale in
February FY 26 in Rebel.
• Major Research Validation: PROTEQT© technology selected for inclusion in a
significant Australian Research Council (ARC) funded brain injury research
program, reinforcing HITIQ’s scientific credibility and leadership in concussion
monitoring with revenue to be received in Q3 FY 26.
• US Collegiate and Women’s Sport Growth: Expanded US collegiate presence
through a research partnership with Smith College Women’s Rugby, supporting
validation in female athlete cohorts and high-growth participation segments.
• Insurance and Institutional Partnerships: Entered a world-first exclusive
partnership with Sportscover to integrate PROTEQT© into sports insurance
offerings, commencing with Hockey Australia and expanding across Sportscover’s
broader portfolio.
• Capital Management Progress: Completed an oversubscribed placement raising
approximately $925,000 before costs, strengthening the Company’s balance
sheet and supporting ongoing commercial execution.
HITIQ.COM
• Strong Shareholder Support: Successfully held the Company’s Annual General
Meeting with all resolutions passed, demonstrating shareholder endorsement of
the Company’s strategy and funding pathway.
Operational and Strategic Updates
HITIQ Limited (ASX: HIQ) continued to execute on its transition from technology
validation to commercial deployment during the December 2025 quarter, with
meaningful progress across retail, international markets, research validation and
strategic partnerships.
The quarter was highlighted by the formal launch of HITIQ’s North American market
strategy through an exclusive Canadian distribution agreement, providing immediate
access to Canada’s extensive collision-sport ecosystem and establishing a scalable entry
point into the United States. This strategy is supported by direct market engagement
and ongoing collegiate research programmes, strengthening PROTEQT© ’s credibility in
elite and institutional environments.
Domestically, HITIQ commenced national retail distribution with Rebel, representing the
Company’s first major Australian consumer retail rollout. This partnership significantly
expands PROTEQT© ’s accessibility to grassroots and community athletes and supports
broader brand awareness ahead of the upcoming sporting season.
HITIQ also continued to build its research and institutional credentials, with PROTEQT©
selected for inclusion in a major Australian Research Council-funded brain injury
research program. This program positions HITIQ at the forefront of evidence-based
concussion research and supports long-term adoption by regulators, sporting bodies,
and medical stakeholders. Additional US collegiate research activity, including the Smith
College Women’s Rugby partnership, further reinforces validation across diverse athlete
cohorts.
Strategic partnerships continued to expand beyond traditional sporting channels, with
the execution of a world-first insurance integration partnership with Sportscover. This
initiative positions PROTEQT© as a risk-management and safety solution embedded
within insurance frameworks, commencing with Hockey Australia and expected to
expand across additional Sportscover-insured sports.
Capital Management and Corporate Activity
During the quarter, HITIQ successfully completed an oversubscribed placement raising
approximately $925,000 before costs. The placement was completed on the same terms
as the Company’s recent rights issue, with strong participation from new and existing
strategic and sophisticated investors. Funds raised are being deployed to support
ongoing product development, commercialisation activities and general working
capital.
The Company also successfully held its Annual General Meeting, with all resolutions
passed. Subsequent to quarter end, the Company issued a General Meeting access letter
in relation to an upcoming General Meeting to seek shareholder approval for director
participation in capital initiatives, consistent with ASX Listing Rule requirements.
HITIQ.COM
Market Outlook
The December 2025 quarter represents a significant step forward in HITIQ’s commercial
execution, with retail distribution now established, North American market entry
underway and multiple validation pathways converting into structured partnerships.
Looking ahead, the Company will focus on scaling retail distribution, converting
international validation and research programmes into recurring commercial contracts,
and expanding PROTEQT© adoption across institutional, insurance and defence-
aligned channels. Manufacturing and supply-chain readiness continues to be aligned
with anticipated demand growth.
Financial Position
The company had cash reserves of $359,670 as at 31 December 2025.
The Company maintained a disciplined approach to cash management during the
quarter, balancing continued investment in research, marketing and commercial rollout
with prudent cost control. The successful completion of the placement, together with
access to existing funding facilities, provides near-term funding visibility as the
Company advances its strategic priorities.
R&D Funding and Loans
HITIQ R&D loan and convertible note facilities remain in place to support working capital
and scale-up activities with Hamil Angel Investments: Total Facility (A$3,1 million at 12.5%
interest for 12 months and $560,000 at 12.5%) and $1,400,000 RDTI Loan facility with No
Bull Pty Ltd for FY26, a related party of the Company’s Largest shareholder, Hamil Angel
Investments. Drawdown to date is $730,000 completed to date.
Related Party Payments
As disclosed in Section 6.1 of the Appendix 4C, payments to related parties during the
quarter comprised executive and non-executive director remuneration, company
secretarial services, and professional advisory fees, all made on arm’s length terms and
consistent with prior periods. Payments totaled A$99,572, comprising of executive and
non-executive director remuneration, company secretarial services, and professional
advisory fees.
• Executive Director Salary and Superannuation $76,246
• Non-Executive Director Fees $16,247
• Bookkeeping, Accounting, and Taxation Services provided by Optima Partners,
o A related party of Non-Executive Director, Philip Carulli who resigned
effective 31 October 2025 $7,079
Conclusion
The December 2025 quarter marks a pivotal phase in HITIQ’s evolution, with the
Company progressing from validation-focused milestones to tangible commercial
execution. Retail expansion, North American market entry, insurance integration, and
HITIQ.COM
major research validation collectively position HITIQ to accelerate growth and advance
its objective of becoming a global leader in concussion and athlete-safety technology.
About HITIQ
HITIQ Limited (ASX: HIQ) operates in the healthcare equipment sector, developing an
end-to-end concussion management and athlete-safety technology platform. The
Company’s PROTEQT© system combines instrumented smart mouthguards with
advanced analytics to support the identification, monitoring, and management of sport-
related brain injury across elite, community, and institutional settings.
HITIQ is targeting a growing global concussion management market spanning sport,
research, defense and healthcare, with applications across both elite and mass-
participation environments.
Authorised for release by the Board of Directors.
For more information, contact: investors@hitiq.co
About HITIQ
HITIQ Limited (ASX: HIQ) operates in the healthcare equipment sector, providing and
further developing a transformative, end-to-end concussion management technology
platform. This platform aims to provide a total concussion ecosystem whereby the
Company’s products support the identification, monitoring and management of sport
related brain injury. HITIQ’s product suite utilises high-end technology that will span
multiple domains – from early detection and surveillance to assessment and rehabilitation
technology tools.
HITIQ is targeting a growing worldwide concussion management market including elite
and recreational sport, clinical practitioners, military, research, and combat sports. The
Company’s first commercial partner is the Australian Football League, with current
strategy initiatives expanding commercially into Rugby League, Rugby Union, Ice Hockey,
Lacrosse, MMA and American Football (particularly the NCAA). The market opportunity
globally represents ~500k athletes within the elite market and ~10million in the consumer
market.
HITIQ.COM
APPENDIX 4C
Quarterly cash flow report for entities
subject to listing rule 4.7b
(a) Name of entity
HITIQ Limited
(b) ABN (c) (d) Quarter ended (“current
quarter”)
53 609 543 213 31 December 2025
(e) Consolidated statement of cash
flows
Current quarter
$A’000
Year to date (6
months)
$A’000
1. Cash flows from operating
activities 91 133
1.1 Receipts from customers
1.2 Payments for
(134) (296)
research and development
product manufacturing and
operating costs
- -
advertising and marketing (66) (234)
leased assets - -
staff costs (584)
(1,462)
administration and corporate costs (738) (1,354)
1.3 Dividends received (see note 3) - -
1.4 Interest received 3 4
1.5 Interest and other costs of finance
paid
- (59)
1.6 Income taxes paid - -
1.7 Government grants and tax
incentives
1,476 1,513
1.8 Other (GST & re-imbursement) - -
1.9 Net cash from / (used in)
operating activities
48 (1,755)
2. Cash flows from investing
activities
- -
2.1 Payments to acquire or for:
(a) Entities
Businesses - -
property, plant and equipment - -
Investments - -
intellectual property - -
other non-current assets - -
2.2 Proceeds from disposal of:
- -
(a) Entities
Businesses - -
property, plant and equipment - -
Investments - -
intellectual property - -
other non-current assets - -
HITIQ.COM
(e) Consolidated statement of cash
flows
Current quarter
$A’000
Year to date (6
months)
$A’000
2.3 Cash flows from loans to other
entities
- -
2.4 Dividends received (see note 3) - -
2.5 Other (provide details if material)
2.6 Net cash from / (used in)
investing activities
- -
-
3. Cash flows from financing
activities 900 1,751
3.1 Proceeds from issues of equity
securities (excluding convertible
debt securities)
3.2 Proceeds from issue of convertible
debt securities
- -
3.3 Proceeds from exercise of options - -
3.4 Transaction costs related to issues
of equity securities or convertible
debt securities
- -
3.5 Proceeds from borrowings 250 730
3.6 Repayment of borrowings (1,326) (1,326)
3.7 Transaction costs related to loans
and borrowings
- -
3.8 Dividends paid - -
3.9 Other (provide details if material) 6 6
3.10 Net cash from / (used in)
financing activities
(170) 1,161
4. Net increase / (decrease) in cash
and cash equivalents for the
period
463 935
4.1 Cash and cash equivalents at
beginning of period
4.2 Net cash from / (used in) operating
activities (item 1.9 above)
48 (1,755)
4.3 Net cash from / (used in) investing
activities (item 2.6 above)
- -
4.4 Net cash from / (used in) financing
activities (item 3.10 above)
(170) 1,161
4.5 Effect of movement in exchange
rates on cash held
18 18
4.6 Cash and cash equivalents at end
of period
359 359
5. (b) Reconciliation of cash and
cash equivalents
at the end of the quarter (as
shown in the consolidated
statement of cash flows) to the
related items in the accounts
Current quarter
$A’000
Previous
quarter
$A’000
5.1 Bank balances 359 463
5.2 Call deposits - -
5.3 Bank overdrafts - -
HITIQ.COM
5.4 Other (provide details) - -
5.5 Cash and cash equivalents at end
of quarter (should equal item 4.6
above)
359 463
(c)
6. (d) Payments to related parties of the entity and
their associates
Current quarter
$A'000
6.1 Aggregate amount of payments to related parties and
their associates included in item 1
100
6.2 Aggregate amount of payments to related parties and
their associates included in item 2
-
Note: if any amounts are shown in items 6.1 or 6.2, your quarterly activity report
must include a description of, and an explanation for, such payments.
The amount at 6.1 includes Director fees and salary (including superannuation)
for the Executive Chairman and Non-Executive Directors.
7. (e) Financing facilities
Note: the term “facility’ includes
all forms of financing
arrangements available to the
entity.
(f) Add notes as necessary for an
understanding of the sources
of finance available to the
entity.
Total facility
amount at
quarter end
$A’000
Amount drawn
at quarter end
$A’000
7.1 Loan facilities 5,060 4,390
7.2 Credit standby arrangements - -
7.3 Other (please specify) - -
7.4 Total financing facilities 5,060 4,390
7.5 Unused financing facilities available at quarter end 670
7.6 Include in the box below a description of each facility above, including the
lender, interest rate, maturity date and whether it is secured or
unsecured. If any additional financing facilities have been entered into or
are proposed to be entered into after quarter end, include a note
providing details of those facilities as well.
The Company has a Convertible Note facility with its major shareholder,
Harmil Angel Investments for $3,100,000 for a period of 12 months at an
interest rate of 12.5% and 560,000 Loan from No Bull at 12.5%. The
Company has an additional $1,400,000 facility with No Bull, an associated
entity of Harmil Investments which is secured against the FY26 R&D loan
with $730,000 drawn to date.
8. (g) Estimated cash available for future operating
activities
$A’000
8.1 Net cash from / (used in) operating activities (item 1.9)
48
8.2 Cash and cash equivalents at quarter end (item 4.6)
359
8.3 Unused finance facilities available at quarter end
(item 7.5) 670
8.4 Total available funding (item 8.2 + item 8.3) 1,029
HITIQ.COM
8.5 Estimated quarters of funding available (item 8.4
divided by item 8.1)
N/A
Note: if the entity has reported positive net operating cash flows in
item 1.9, answer item 8.5 as “N/A”. Otherwise, a figure for the estimated
quarters of funding available must be included in item 8.5.
8.6 If item 8.5 is less than 2 quarters, please provide answers to the following
questions: N/A
8.6.1 Does the entity expect that it will continue to have the current level
of net operating cash flows for the time being and, if not, why not?
N/A
8.6.2 Has the entity taken any steps, or does it propose to take any steps,
to raise further cash to fund its operations and, if so, what are those steps
and how likely does it believe that they will be successful?
Answer: N/A
8.6.3 Does the entity expect to be able to continue its operations and to
meet its business objectives and, if so, on what basis?
Answer: N/A
Note: where item 8.5 is less than 2 quarters, all of questions 8.6.1, 8.6.2 and
8.6.3 above must be answered.
(h) Compliance statement
1 This statement has been prepared in accordance with accounting standards and
policies which comply with Listing Rule 19.11A.
2 This statement gives a true and fair view of the matters disclosed.
Date: 30 January 2026
Authorised by: The Board of HITIQ Limited
(Name of body or officer authorising release – see note 4)
Notes
1. This quarterly cash flow report and the accompanying activity report provide a basis for informing the market
about the entity’s activities for the past quarter, how they have been financed and the effect this has had on its
cash position. An entity that wishes to disclose additional information over and above the minimum required
under the Listing Rules is encouraged to do so.
2. If this quarterly cash flow report has been prepared in accordance with Australian Accounting Standards, the
definitions in, and provisions of, AASB 107: Statement of Cash Flows apply to this report. If this quarterly cash flow
report has been prepared in accordance with other accounting standards agreed by ASX pursuant to Listing
Rule 19.11A, the corresponding equivalent standard applies to this report.
3. Dividends received may be classified either as cash flows from operating activities or cash flows from investing
activities, depending on the accounting policy of the entity.
4. If this report has been authorised for release to the market by your board of directors, you can insert here: “By the
board”. If it has been authorised for release to the market by a committee of your board of directors, you can insert
here: “By the [name of board committee – e.g., Audit and Risk Committee]”. If it has been authorised for release to
the market by a disclosure committee, you can insert here: “By the Disclosure Committee”.
5. If this report has been authorised for release to the market by your board of directors and you wish to hold yourself
out as complying with recommendation 4.2 of the ASX Corporate Governance Council’s Corporate Governance
Principles and Recommendations, the board should have received a declaration from its CEO and CFO that, in
their opinion, the financial records of the entity have been properly maintained, that this report complies with the
appropriate accounting standards and gives a true and fair view of the cash flows of the entity, and that their
opinion has been formed on the basis of a sound system of risk management and internal control which is
operating effectively.
Share your feedback
Discover